Terms: = Head and neck cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Treatment
55 results:
1. The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.
Iesato A; Li S; Sadow PM; Abbasian M; Nazarian A; Lawler J; Nucera C
Thyroid; 2023 Jul; 33(7):835-848. PubMed ID: 37171127
[No Abstract] [Full Text] [Related]
2. A Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma.
Zhang Y; Luo F; Ma YX; Liu QW; Yang YP; Fang WF; Huang Y; Zhou T; Li J; Pan HM; Yang L; Qin SK; Zhao HY; Zhang L
Oncologist; 2022 Jun; 27(6):e453-e462. PubMed ID: 35445718
[TBL] [Abstract] [Full Text] [Related]
3. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
4. Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma.
Moy RH; Greally M; Chou JF; Li J; Desai AM; Chalasani SB; Won E; Kelsen DP; Ilson DH; Janjigian YY; Capanu M; Ku GY
Cancer Chemother Pharmacol; 2022 Feb; 89(2):255-265. PubMed ID: 35066693
[TBL] [Abstract] [Full Text] [Related]
5. Determination of cytokine profile and associated genes of the signaling pathway in HNSCC.
Kalayci Yigin A; Azzawri A; Ozturk K; Cora T; Seven M
J Recept Signal Transduct Res; 2022 Oct; 42(5):462-468. PubMed ID: 34886759
[TBL] [Abstract] [Full Text] [Related]
6. Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid cancer.
Iesato A; Nucera C
Adv Exp Med Biol; 2021; 1329():253-269. PubMed ID: 34664244
[TBL] [Abstract] [Full Text] [Related]
7. Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Li D; Chi Y; Chen X; Ge M; Zhang Y; Guo Z; Wang J; Chen J; Zhang J; Cheng Y; Li Z; Liu H; Qin J; Zhu J; Cheng R; Xu Z; Zheng X; Tang P; Gao M
Clin Cancer Res; 2021 Jul; 27(13):3567-3575. PubMed ID: 33832949
[TBL] [Abstract] [Full Text] [Related]
8. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
Abe I; Lam AK
Curr Oncol Rep; 2021 Feb; 23(3):31. PubMed ID: 33582932
[TBL] [Abstract] [Full Text] [Related]
9. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
[TBL] [Abstract] [Full Text] [Related]
10. Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and pdgfrα/β Expression in SCC According to HPV16 Status.
Huber L; Birk R; Rotter N; Aderhold C; Lammert A; Jungbauer F; Kramer B
Anticancer Res; 2020 Feb; 40(2):825-835. PubMed ID: 32014925
[TBL] [Abstract] [Full Text] [Related]
11. Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non-Small-Cell Lung cancer.
Wheatley-Price P; Gadgeel S; Takahashi T; Li X; Dar M; Blumenschein GR
Clin Lung Cancer; 2019 May; 20(3):e362-e368. PubMed ID: 30685114
[TBL] [Abstract] [Full Text] [Related]
12. PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma.
Liu T; Ma W; Xu H; Huang M; Zhang D; He Z; Zhang L; Brem S; O'Rourke DM; Gong Y; Mou Y; Zhang Z; Fan Y
Nat Commun; 2018 Aug; 9(1):3439. PubMed ID: 30150753
[TBL] [Abstract] [Full Text] [Related]
13. Lenvatinib in the Therapy of Aggressive Thyroid cancer: State of the Art and New Perspectives with Patents Recently Applied.
Ferrari SM; Ruffilli I; Centanni M; Virili C; Materazzi G; Alexopoulou M; Miccoli M; Antonelli A; Fallahi P
Recent Pat Anticancer Drug Discov; 2018; 13(2):201-208. PubMed ID: 29468981
[TBL] [Abstract] [Full Text] [Related]
14. Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.
Kashyap MK; Abdel-Rahman O
Mol Cancer; 2018 Feb; 17(1):54. PubMed ID: 29455652
[TBL] [Abstract] [Full Text] [Related]
15. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma.
Hocker SE; Higginbotham ML; Schermerhorn T; Henningson J
Res Vet Sci; 2017 Dec; 115():484-489. PubMed ID: 28783596
[TBL] [Abstract] [Full Text] [Related]
16. Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway.
Li H; Shi B; Li Y; Yin F
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28266802
[TBL] [Abstract] [Full Text] [Related]
17. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract] [Full Text] [Related]
18. [Lenvatinib in radioiodine refractory thyroid carcinomas].
de la Fouchardiere C
Bull Cancer; 2016 Nov; 103(11):905-910. PubMed ID: 27817859
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy of lenvatinib in treating thyroid cancer.
Krajewska J; Kukulska A; Jarzab B
Expert Opin Pharmacother; 2016 Aug; 17(12):1683-91. PubMed ID: 27398740
[TBL] [Abstract] [Full Text] [Related]
20. pdgfrα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
[TBL] [Abstract] [Full Text] [Related]
[Next]
